- Home
- XRAY vs IMVT Comparison
XRAY vs IMVT Comparison
Compare XRAY & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRAY
- IMVT
- Stock Information
- Founded
- XRAY 1899
- IMVT N/A
- Country
- XRAY United States
- IMVT United States
- Employees
- XRAY N/A
- IMVT N/A
- Industry
- XRAY Medical/Dental Instruments
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XRAY Health Care
- IMVT Health Care
- Exchange
- XRAY Nasdaq
- IMVT Nasdaq
- Market Cap
- XRAY 3.1B
- IMVT 3.4B
- IPO Year
- XRAY 1987
- IMVT N/A
- Fundamental
- Price
- XRAY $14.93
- IMVT $18.37
- Analyst Decision
- XRAY Hold
- IMVT Strong Buy
- Analyst Count
- XRAY 13
- IMVT 11
- Target Price
- XRAY $23.36
- IMVT $44.13
- AVG Volume (30 Days)
- XRAY 3.4M
- IMVT 1.9M
- Earning Date
- XRAY 05-01-2025
- IMVT 02-06-2025
- Dividend Yield
- XRAY 4.29%
- IMVT N/A
- EPS Growth
- XRAY N/A
- IMVT N/A
- EPS
- XRAY N/A
- IMVT N/A
- Revenue
- XRAY $3,793,000,000.00
- IMVT N/A
- Revenue This Year
- XRAY N/A
- IMVT $108.88
- Revenue Next Year
- XRAY $2.56
- IMVT N/A
- P/E Ratio
- XRAY N/A
- IMVT N/A
- Revenue Growth
- XRAY N/A
- IMVT N/A
- 52 Week Low
- XRAY $14.78
- IMVT $17.01
- 52 Week High
- XRAY $33.22
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- XRAY 30.25
- IMVT 42.05
- Support Level
- XRAY $15.34
- IMVT $17.49
- Resistance Level
- XRAY $16.02
- IMVT $18.96
- Average True Range (ATR)
- XRAY 0.49
- IMVT 1.23
- MACD
- XRAY 0.06
- IMVT -0.01
- Stochastic Oscillator
- XRAY 11.36
- IMVT 39.65
About XRAY DENTSPLY SIRONA Inc.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).